Clinical Profile and Underdiagnosis of Pulmonary Hypertension in US Veteran Patients

被引:48
|
作者
Maron, Bradley A. [1 ,2 ,3 ]
Choudhary, Gaurav [5 ]
Khan, Umar A. [1 ]
Jankowich, Matthew D. [5 ]
McChesney, Hope [1 ]
Ferrazzani, Sarah J. [1 ]
Gaddam, Sainath [5 ]
Sharma, Satish [5 ]
Opotowsky, Alexander R. [4 ]
Bhatt, Deepak L. [1 ,2 ,3 ]
Rocco, Thomas P. [1 ,2 ,3 ]
Aragam, Jayashri R. [1 ,2 ,3 ]
机构
[1] Vet Affairs Boston Healthcare Syst, Dept Cardiol, Boston, MA USA
[2] Brigham & Womens Hosp, Div Cardiovasc Med, Dept Internal Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Childrens Hosp Boston, Dept Cardiol, Boston Adult Congenital Heart Program, Boston, MA USA
[5] Brown Univ, Dept Med, Alpert Med Sch, Providence Vet Affairs Med Ctr, Providence, RI 02912 USA
基金
美国国家卫生研究院;
关键词
diagnosis; epidemiology; pulmonary hypertension; SYSTOLIC HEART-FAILURE; ARTERIAL-HYPERTENSION; EJECTION FRACTION; EXERCISE CAPACITY; PREVALENCE; SILDENAFIL; DIAGNOSIS; FIBROSIS; OUTCOMES;
D O I
10.1161/CIRCHEARTFAILURE.112.000091
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Pulmonary hypertension (PH) is a key contributor to cardiovascular morbidity and early mortality; however, reports are lacking on the epidemiology of PH in at-risk patient populations. Methods and Results The echocardiography registries from 2 major Veterans Affairs hospitals were accessed to identify patients with at least moderate PH, defined here as a pulmonary artery systolic pressure 60 mm Hg detected echocardiographically. From a total of 10 471 individual patient transthoracic echocardiograms, we identified moderate or severe PH in 340 patients (332 men; mean, 77 years; mean pulmonary artery systolic pressure, 69.410.5 mm Hg), of which PH was listed as a diagnosis in the medical record for only 59 (17.3%). At a mean of 832 days (0-4817 days) following echocardiography diagnosing PH, 150 (44.1%) patients were deceased. PH was present without substantial left heart remodeling: the mean left ventricular ejection fraction was 0.50 +/- 0.16, left ventricular end-diastolic dimension was 5.0 +/- 0.9 cm, and left atrial dimension was 4.4 +/- 0.7 cm. Cardiac catheterization (n=122, 36%) demonstrated a mean pulmonary artery pressure of 40.5 +/- 11.4 mm Hg, pulmonary capillary wedge pressure of 22.6 +/- 8.9 mm Hg, and pulmonary vascular resistance of 4.6 +/- 2.9 Wood units. Diagnostic strategies for PH were variable and often incomplete; for example, only 16% of appropriate patients were assessed with a nuclear ventilation/perfusion scan for thromboembolic causes of PH. Conclusions In an at-risk patient population, PH is underdiagnosed and associated with substantial mortality. Enhanced awareness is necessary among practitioners regarding contemporary PH diagnostic strategies.
引用
收藏
页码:906 / 912
页数:7
相关论文
共 50 条
  • [1] SEVERE PULMONARY HYPERTENSION IS UNDER RECOGNIZED IN US VETERAN PATIENTS
    Maron, Bradley
    Choudhary, Gaurav
    Opotowsky, Sasha
    Bhatt, Deepak
    Aragam, Jayashri
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1291 - E1291
  • [2] Effect of Hemodynamic Profile on Mortality in Veteran Patients With Pulmonary Hypertension Undergoing TAVR
    Burke, Lucas
    Doukas, Demetrios
    Pow, Timothy
    Gozdecki, Leo
    Mathew, Verghese
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B694 - B694
  • [3] The Underdiagnosis of Pulmonary Hypertension in Myelofibrosis
    Thachil, Jecko
    [J]. AMERICAN JOURNAL OF MEDICINE, 2010, 123 (06): : E13 - E13
  • [4] The Underdiagnosis of Pulmonary Hypertension in Myelofibrosis Reply
    Brastianos, Priscilla Kaliopi
    Streiff, Michael
    [J]. AMERICAN JOURNAL OF MEDICINE, 2010, 123 (06): : E14 - E14
  • [5] DIFFERENCES IN THE PROFILE AND DIAGNOSIS OF PULMONARY ARTERIAL HYPERTENSION PATIENTS IN THE EU/US AND LATIN AMERICA
    Allie, Nicole
    Rosli, Arina
    Rogers, Denay
    Brown, Sarah
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1929 - 1929
  • [6] Risk of underdiagnosis of hypertension in schizophrenia patients
    Castillo-Sanchez, Miguel
    Fabregas-Escurriola, Mireia
    Berge-Baquero, Daniel
    Isabel Fernandez-San Martin, Ma
    Foguet Boreu, Quinti
    Goday-Arno, Albert
    [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION, 2018, 40 (02) : 167 - 174
  • [7] CARE AND CHARACTERISTICS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN US CLINICAL PRACTICE
    Frost, Adaani
    Chakinala, Murali
    Frantz, Robert
    Lancaster, Lisa
    Nathan, Steven
    Oudiz, Ronald
    Dee, Anne
    Milligan, Scott
    Narayan, Veena
    Panjabi, Sumeet
    Farber, Harrison
    [J]. CHEST, 2021, 160 (04) : 2287A - 2289A
  • [8] METALLOMICS PROFILE IN PULMONARY ARTERIAL HYPERTENSION PATIENTS
    Huang, Jiapeng
    Hopkins, C. Danielle
    Wessel, Caitlin
    Chen, Oscar
    Akca, Ozan
    Cai, Lu
    El-Kersh, Karim
    [J]. CHEST, 2021, 160 (04) : 2299A - 2300A
  • [9] CLINICAL AND HEMODYNAMIC PROFILE OF PATIENTS WITH IDIOPATHIC ARTERIAL PULMONARY HYPERTENSION DEPENDING ON PULMONARY ARTERY VASODILATOR REACTIVITY
    Paramonov, V.
    Martynyuk, T.
    Danilov, N.
    Chazova, I. E.
    [J]. JOURNAL OF HYPERTENSION, 2015, 33 : E202 - E202
  • [10] microRNA profile in COPD patients with and without pulmonary hypertension
    Hertig, Dinah
    Leuenberger, Caroline
    Rechsteiner, Thomas
    Soltermann, Alex
    Ulrich, Silvia
    Weder, Walter
    Kohler, Malcolm
    Huber, Lars
    Brock, Matthias
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46